Profound Medical (PROF) Receivables (2018 - 2026)

Profound Medical's Receivables history runs 9 years deep, the most recent figure standing at $9.6 million for Q1 2026.

• In Q1 2026, Receivables rose 56.31% year-over-year to $9.6 million; the TTM figure through Mar 2026 stood at $9.6 million (up 56.31% YoY), while the FY2025 annual figure was $7.3 million, down 1.02% from the prior year.
• Receivables was $9.6 million for Q1 2026 at Profound Medical, up from $7.3 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $9.6 million in Q1 2026 to a low of $3.2 million in Q4 2023.
• Historically, Receivables has averaged $6.6 million across 5 years, with a median of $6.8 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Receivables plunged 50.17% in 2023, then jumped 132.17% in 2024.
• A 5-year view of Receivables shows it stood at $6.4 million in 2022, then plunged by 50.17% to $3.2 million in 2023, then jumped by 132.17% to $7.4 million in 2024, then declined by 1.02% to $7.3 million in 2025, then jumped by 31.85% to $9.6 million in 2026.
• The last three Receivables figures came in at $9.6 million (Q1 2026), $7.3 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.